Vol 8, No 3 (2012)
- Year: 2012
- Published: 30.09.2012
- Articles: 17
- URL: https://oncourology.abvpress.ru/oncur/issue/view/32
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER
THE DIAGNOSIS AND PREDICTION OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE, BY APPLYING CLINICAL METHODS AND FISH ANALYSIS (A REVIEW OF LITERATURE)
Abstract
43-50
URODYNAMIC FINDINGS IN ASSESSMENT OF THE RESULTS OF PARTIAL CYSTECTOMY FOR BLADDER CANCER
Abstract
Objectives. We determined the role of urodynamic results on the estimation of treatment efficiency of patients with bladder cancer.
Subjects and methods. The study consequently included 160 patients receiving TUR and open resection in 2005−2009. Quality of life was assessed using the IPSS, QoL and International Inventory of Erectile Function (IIEF). Uroflowmetry, bladder diary were carried out to determine lower urinary tract symptoms befor treatment, 3 and 12 mo later.
Results. In 3 months after operation statistically authentic changes of semiotics were noted. But in a year all indicators were in norm or approached to it.
Conclusions. Urodinamic methods of research can be recommended to application as criterion of efficiency of operative intervention and for definition of rehabilitation times in the postoperative period in a complex with other methods.
51-54
QUALITY OF LIFE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER STAGES T2B AND T3A AFTER SURGICAL TREATMENT
Abstract
The article represents the study of quality of life in patients with muscle-invasive bladder cancer stages T2b and T3a after surgery, depending on the operation type. The study was conducted using questionnaires EORTC QLQ-30 and FACT-BL. The best levels of quality of life were observed in patients after organ-saving treatment of muscle-invasive bladder cancer.
55-59
DIFFERENTIATED SURGICAL TACTICS IN PATIENTS WITH LOCALLY ADVANCED BLADDER INVOLVEMENT PELVIC TUMORS
Abstract
An analysis of surgical treatment of 154 patients with locally advanced and recurrent malignant tumors of the pelvic organs with secondary lesions of the bladder was performed. Described surgical technique used for resection and reconstructive stages of surgery. In 73.4 % of the volume of the intervention was complete or anterior pelvic exenteration. Morbidity after operations was 30.5 %, postoperative mortality — 7.8 %. The perspective of large-scale interventions to improve outcomes of patients with tumors of the pelvic localization is marked.
60-66
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER
HISTOSPECTROPHOTOMETRICAL AND IMMUNOHISTOCHEMISTRICAL RESEARCH OF RENAL INTRATUBULAR NEOPLASIA IN PERITUMOUROUS ZONE OF A RENAL CARCINOMA
Abstract
19-23
SOME SPECIFIC FEATURES OF THE DIAGNOSIS AND TREATMENT OF KIDNEY CANCER IN RUSSIA: PRELIMINARY RESULTS OF A MULTICENTER COOPERATIVE STUDY
Abstract
24-30
USE OF INTRAOPERATIVE NAVIGATION DURING ORGAN-SAVING SURGERY FOR KIDNEY TUMOR
Abstract
31-36
EFFICIENCY OF TARGETED THERAPY USED IN THE HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER
Abstract
37-42
PROSTATE CANCER
PROGNOSTIC VALUE OF THE BASELINE VALUES OF SERUM TESTOSTERONE AND FREE ANDROGEN INDEX IN PATIENTS WITH PROSTATE CANCER
Abstract
The growing incidence of prostate cancer (PC) and its variable nature are an important problem today. PC is distinguished by its latent ability in many cases, which makes its screening difficult.
Prostate-specific antigen (PSA) is one of the most common tumor markers of PC, which are used for mass male screening. However, the detection rate of PC in men with normal PSA values is also very high. This promotes an active search for new markers and predictors of PC.
The effect of androgens on hormonal carcinogenesis in the prostate suggests that the analysis of serum testosterone concentrations and free androgen index may be made in patients with low PSA levels in the early diagnosis and prognosis of PC.
67-71
ВЗАИМОСВЯЗЬ ПРОСТАТИЧЕСКИХ КАМНЕЙ И РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ
Abstract
The impact of prostatoliths (PL) on the level of prostate-specific antigen (PSA) was evaluated and their association with prostate cancer (PC) was studied in 145 patients with benign hyperplasia and cancer of the prostate. No statistically significant increase in PSA levels in the presence of PL was found. A chronic inflammatory process in the prostate was more common in PC concurrent with PL, which is an indirect sign
of a possible correlation between PL and PC. Final conclusions about the oncourological aspects of PL can be made only after further investigations in this area.
72-75
COMPLICATIONS OF EXTRAPERITONEOSCOPIC RADICAL PROSTATECTOMIES
Abstract
Background. Radical prostatectomy (RPE) is today the gold standard treatment option for locally advanced prostate cancer (PC). These operations are performed both openly and using video-assisted endosurgery. Since 2009, the Research Institute of Urology has been made 70 extraperitoneoscopic RPEs (ERPE).
Objective: to assess the complications of ERPE with the validated Clavien complication scale.
Materials and methods. The authors retrospectively analyzed the case histories of 70 patients with locally advanced PC who had undergone ERPE. The complications were allocated to 3 groups: intraoperative, early (within 1 month) and late (over 1 month) postoperative ones. All found complications were stratified using Clavien classification scale.
Results. The total number of ERPE complications accounted for 35.7%. The most common complications, such as anastomotic incompetence and blood loss that required hemotransfusion, were 9.8 and 11.3%, respectively. Rectal damage was intraoperatively found in 2 cases. Obturator nerve damage was also recognized intraoperatively and did not result in the occurrence of neurological symptoms. The severest complication (Clavien scale grade V) was pulmonary embolism causing death.
Conclusion. Postoperative complications of ERPE were observed in a small percentage of the patients and posed no serious threat to their life. The analysis of the complications of ERPE suggests that this treatment for locally advanced PC is a current safe and low-traumatic method.
76-79
ROBOT-ASSISTED RADICAL PROSTATECTOMY IN THE TREATMENT OF CLINICALLY LOCALIZED PROSTATE CANCER (A REVIEW OF LITERATURE)
Abstract
80-87
SMALL CELL CARCINOMA OF THE PROSTATE: CLINICAL AND MORPHOLOGICAL ASPECTS
Abstract
Small cell carcinoma of the prostate is a rare and very aggressive tumor. Primary emphasis is laid on the morphological and immunohistochemical characteristics of this type of a tumor, the clinical presentations of the disease, performed treatment, and its response. Three clinical cases of small cell carcinoma of the prostate with their further discussion are described.
77-81
CLINICAL CASE
VERIFICATION OF A TUMOR LESION OF INTRAPELVIC LYMPH NODES AFTER RADICAL PROSTATECTOMY. THE FIRST EXPERIENCE
Abstract
Objective: to study the possibilities of transrectal ultrasound scan (TRUS) and magnetic resonance imaging (MRI) in identifying and verifying a tumor lesion of intrapelvic lymph nodes (LN) in patients with biochemical recurrence after radical prostatectomy.
Subjects and methods. Metastatic tumor lesion of intrapelvic LNs was verified in 4 patients by transrectal ultrasound (US)-guided needle biopsies. All the patients underwent multi-parametric MRI studies and TRUS.
Results. The application of current MRI technologies (for qualitative and quantitative analysis of diffusion-weighted images and for postcontrast sequences) could detect and judge with confidence the metastatic lesion of intrapelvic LNs. TRUS permits clearly visualizing pathologically altered LNs, by taking into account their MRI pattern and verifying their tumor lesion by US-guided core needle biopsy.
Conclusion. The combined use of multi-parametric MRI and TRUS provides a means for diagnosing and verifying the tumor lesion of pelvic LNs in patients after prostatectomy.
88-91
LECTURE
MAINTENANCE INTRAVESICULAR THERAPY WITH BCG VACCINE AS A STANDARD FOR THE PREVENTION AND TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER IN MODERATE AND HIGH RISK GROUPS
Abstract
12-17
ANNIVERSARIES
96
98




